InnoCan Pharma Corporation (CSE:INNO)
Canada
· Delayed Price · Currency is CAD 6.50
+0.60 (10.17%)
Mar 9, 2026, 3:47 PM EST
InnoCan Pharma Revenue
InnoCan Pharma had revenue of $6.82M USD in the quarter ending September 30, 2025, a decrease of -20.90%. This brings the company's revenue in the last twelve months to $27.03M, down -6.58% year-over-year. In the year 2024, InnoCan Pharma had annual revenue of $29.44M with 115.55% growth.
Revenue (ttm)
$27.03M
Revenue Growth
-6.58%
P/S Ratio
0.71
Revenue / Employee
$5.41M
Employees
5
Market Cap
26.54M CAD
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Loblaw Companies | 63.90B |
| Dollarama | 7.04B |
| George Weston | 64.51B |
| Metro | 22.18B |
| Swiss Water Decaffeinated Coffee | 241.96M |
| Burcon NutraScience | 1.48M |
| HYTN Innovations | 2.94M |
| Inter-Rock Minerals | 146.72M |